Sign Out
Pregnancy: Animal studies do not indicate harmful effects with respect to effects on pregnancy or embryonal/foetal development.
Limited data from available pregnancy databases do not suggest a causal relationship between Oxair Tablets and malformations (i.e. limb defects) that have been rarely reported in worldwide post-marketing experience.
Oxair Tablets may be used during pregnancy only if it is considered to be clearly essential.
Breast-feeding: Studies in rats have shown that montelukast is excreted in milk. It is unknown whether montelukast/metabolites are excreted in human milk.
Oxair Tablets may be used in breast-feeding only if it is considered to be clearly essential.
